Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Blood Test Could Predict Young Adults Who Might Go On To Develop Diseases of Aging

By LabMedica International staff writers
Posted on 13 Mar 2024

Everyone ages differently and two people can often have the same chronological age, but very different biological ages. The future of medicine lies in knowing in advance about how someone is aging and designing personalized interventions to delay disease and extend a person’s health span. Researchers have now identified blood markers that are indicative of healthy aging or accelerated aging processes. These markers offer insights into a person’s biological age—essentially, the rate at which their cells and organs are aging, independent of their actual date of birth. This breakthrough research illuminates the biological pathways and substances that might be foundational to the aging process, providing clues as to why aging varies among individuals. It also proposes potential targets for treatments aimed at slowing the aging process and enhancing the duration of good health. This could lead to the development of a blood test capable of determining biological age in younger adults or identifying individuals at risk of developing age-related diseases.

In the study, researchers at University of Pittsburgh (Pittsburgh, PA, USA) compared 196 older individuals, categorizing them as either healthy or rapid agers based on their performance in simple walking tests. These tests are significant as walking ability integrates cardiovascular, muscular, and neurological health, making it a strong predictor of hospitalization and mortality risk in older adults. The study was unique because it compared rapid agers, aged between 65 and 75 who struggled with these physical tasks but were chronologically younger, against healthy agers, who were 75 and older but could complete the tasks without resting. This approach allowed the researchers to focus on biological rather than chronological age, setting their study apart from others that typically compare young adults to older populations. Through metabolomic analysis of blood samples from both groups, clear differences in metabolites were found between healthy and rapid agers, suggesting that blood metabolites can reflect biological age.

The researchers then established the Healthy Aging Metabolic (HAM) Index from 25 specific metabolites. This index proved more effective in differentiating between healthy and rapid agers than other aging measures. When applied to a separate group of older adults from a study in Wisconsin, the HAM Index successfully predicted individuals' ability to walk outside for 10 minutes without stopping with about 68% accuracy. Further analysis through an artificial intelligence model helped identify three key metabolites as potential promoters of healthy aging or accelerators of rapid aging. Future investigations will explore how these metabolites and their associated molecular pathways influence the aging process, with the goal of finding interventions to slow aging. The researchers also aim to study how younger individuals' metabolomes change over time in order to create a blood test that can estimate the biological age in young adults or predict the onset of aging diseases.

“While it’s great that we can predict biological aging in older adults, what would be even more exciting is a blood test that, for example, can tell someone who’s 35 that they have a biological age more like a 45-year-old,” said Aditi Gurkar, Ph.D., assistant professor of geriatric medicine at Pitt’s School of Medicine. “That person could then think about changing aspects of their lifestyle early — whether that’s improving their sleep, diet or exercise regime — to hopefully reverse their biological age.”

Related Links:
University of Pittsburgh

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.